α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy
α-Lipoic acid (thioctic) (ALA) is the most applicable pharmacological drug for treatment of diabetic polyneuropathy. The articles explores the results of experimental studies on α-Lipoic acid effect upon formation mechanisms of peripheral nerves affection under hyperglycemia and also the data of num...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2016-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1577 |
| _version_ | 1797841741115555840 |
|---|---|
| author | I. A. Strokov A. S. Phokina |
| author_facet | I. A. Strokov A. S. Phokina |
| author_sort | I. A. Strokov |
| collection | DOAJ |
| description | α-Lipoic acid (thioctic) (ALA) is the most applicable pharmacological drug for treatment of diabetic polyneuropathy. The articles explores the results of experimental studies on α-Lipoic acid effect upon formation mechanisms of peripheral nerves affection under hyperglycemia and also the data of numerous randomized controlled trials and meta-analyses on studying ALA efficiency under symptomatic diabetic polyneuropathy. It was proved that amelioration of patients with diabetic polyneuropathy is observed both while using ALA infusions and tableted form of the drug. The authors conclude that α-lipoic acid is a drug for treatment of pathogenetic development mechanisms of diabetic polyneuropathy with the most demonstrated efficiency. |
| first_indexed | 2024-04-09T16:36:32Z |
| format | Article |
| id | doaj.art-086492b5f10241c8a56ccfad5c119c61 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:36:32Z |
| publishDate | 2016-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-086492b5f10241c8a56ccfad5c119c612023-04-23T06:56:52ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902016-12-01017283310.21518/2079-701X-2016-17-28-331570α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathyI. A. Strokov0A. S. Phokina1First Moscow State Medical UniversityFirst Moscow State Medical Universityα-Lipoic acid (thioctic) (ALA) is the most applicable pharmacological drug for treatment of diabetic polyneuropathy. The articles explores the results of experimental studies on α-Lipoic acid effect upon formation mechanisms of peripheral nerves affection under hyperglycemia and also the data of numerous randomized controlled trials and meta-analyses on studying ALA efficiency under symptomatic diabetic polyneuropathy. It was proved that amelioration of patients with diabetic polyneuropathy is observed both while using ALA infusions and tableted form of the drug. The authors conclude that α-lipoic acid is a drug for treatment of pathogenetic development mechanisms of diabetic polyneuropathy with the most demonstrated efficiency.https://www.med-sovet.pro/jour/article/view/1577diabetic polyneuropathypathogenesis of the diabetic polyneuropathypathogenetic therapy of diabetic polyneuropathyalpha-lipoic acidberlitionpain syndrome in diabetic polyneuropathy |
| spellingShingle | I. A. Strokov A. S. Phokina α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy Медицинский совет diabetic polyneuropathy pathogenesis of the diabetic polyneuropathy pathogenetic therapy of diabetic polyneuropathy alpha-lipoic acid berlition pain syndrome in diabetic polyneuropathy |
| title | α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy |
| title_full | α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy |
| title_fullStr | α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy |
| title_full_unstemmed | α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy |
| title_short | α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy |
| title_sort | α lipoic acid as the main pharmacological drug for in and outpatient treatment of diabetic polyneuropathy |
| topic | diabetic polyneuropathy pathogenesis of the diabetic polyneuropathy pathogenetic therapy of diabetic polyneuropathy alpha-lipoic acid berlition pain syndrome in diabetic polyneuropathy |
| url | https://www.med-sovet.pro/jour/article/view/1577 |
| work_keys_str_mv | AT iastrokov alipoicacidasthemainpharmacologicaldrugforinandoutpatienttreatmentofdiabeticpolyneuropathy AT asphokina alipoicacidasthemainpharmacologicaldrugforinandoutpatienttreatmentofdiabeticpolyneuropathy |